DD vs RNXT · P/E 127, rev $12.39B vs rev $266.0K
Dupont De Nemours Inc (DD) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the DD and RNXT stock pages for the full models.
Not investment advice.